APA

Ogata F., Kobayashi M., Akuta N., Osawa M., Fujiyama S., Kawamura Y., Sezaki H., Hosaka T., Kobayashi M., Saitoh S., Suzuki Y., Suzuki F., Arase Y., Ikeda K. & Kumada H. (20171023). Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease. : Oncology.

Chicago

Ogata Fumihiro, Kobayashi Masahiro, Akuta Norio, Osawa Mitutaka, Fujiyama Shunichiro, Kawamura Yusuke, Sezaki Hitomi, Hosaka Tetsuya, Kobayashi Mariko, Saitoh Satoshi, Suzuki Yoshiyuki, Suzuki Fumitaka, Arase Yasuji, Ikeda Kenji and Kumada Hiromitsu. 20171023. Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease. : Oncology.

Harvard

Ogata F., Kobayashi M., Akuta N., Osawa M., Fujiyama S., Kawamura Y., Sezaki H., Hosaka T., Kobayashi M., Saitoh S., Suzuki Y., Suzuki F., Arase Y., Ikeda K. and Kumada H. (20171023). Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease. : Oncology.

MLA

Ogata Fumihiro, Kobayashi Masahiro, Akuta Norio, Osawa Mitutaka, Fujiyama Shunichiro, Kawamura Yusuke, Sezaki Hitomi, Hosaka Tetsuya, Kobayashi Mariko, Saitoh Satoshi, Suzuki Yoshiyuki, Suzuki Fumitaka, Arase Yasuji, Ikeda Kenji and Kumada Hiromitsu. Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease. : Oncology. 20171023.